Research Paper on Expert opinions from the Polish Society of Allergology on how to treat asthma that is difficult to treat

Description

Title: Expert opinions from the Polish Society of Allergology on how to treat asthma that is difficult to treat

Abstract: The primary goal of treating asthma is to manage its symptoms, but despite the availability of prescription medications and treatment regimens, the condition is not sufficiently under control. Due to factors unrelated to the illness, the best control cannot be achieved in cases of difficult-to-treat asthma. Inadequate treatment plans (low therapy adherence and compliance), improper inhalation techniques, inadequate symptom control using the classes of medications available, incomplete response to treatment (non-responders, steroid-resistance), incorrect diagnosis of asthma or comorbidities, and environmental factors are some of the factors that make asthma control worse. Take therapeutic decisions with the patient, evaluate the likelihood of non-compliance, perform thorough diagnostics and start treating coexisting diseases, perform differential diagnosis of conditions that mimic asthma, educate the patient about the inhalation technique and check it, remove unfavorable environmental factors, and modify current treatment are all recommended in order to achieve the best asthma control. Ultra-long-acting beta2-agonists, long-acting muscarine receptor antagonists (LAMA), monoclonal antibodies, and non-pharmacological interventions are some of the new treatment options for asthma patients. Tiotropium bromide is the only LAMA approved for the treatment of asthma. The results of the analyses showed that tiotropium had a high efficacy in terms of bettering lung function parameters and delaying the onset of the first asthma attack. GINA (Global Initiative for Asthma) 2014 recommends it as an add-on therapy at asthma treatment steps 4 and 5. From a medical and financial perspective, it is critical to have the best asthma control possible.

Keywords: asthma, bronchodilators, asthma control, difficult-to-treat asthma

Paper Quality: SCOPUS / Web of Science Level Research Paper

Subject: Advances in Respiratory Medicine

Writer Experience: 20+ Years

Plagiarism Report: Turnitin Plagiarism Report will be less than 10%

Restriction: Only one author may purchase a single paper. The paper will then indicate that it is out of stock.

What will I get after the purchase?

A turnitin plagiarism report of less than 10% in a pdf file and a full research paper in a word document.

In case you have any questions related to this research paper, please feel free to call/ WhatsApp on +919726999915